Size-variable strain-specific protective antigen for Potomac horse fever
a strain-specific, potomac horse fever technology, applied in the field of size-variable strain-specific protective antigen for potomac horse fever, can solve the problems of substantial economic loss to the equine industry, all attempts to reveal the mode of transmission of risticii/risticii have failed, etc., and achieve the effect of protecting the immune response and more effective vaccines
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
Isolation of Strain Specific Surface Antigen Gene of Ehrlichia risticii
Ehrlichia risticii Strains and DNA Preparation:
[0034]Two different strains of E. risticii were used for this study. The original E. risticii strain (25D) was isolated in 1984, during the initial outbreaks of PHF near the Potomac River bank in Maryland and Virginia. Recently the inventors isolated a new strain of E. risticii (90-12) from a vaccinated horse suffering from clinical PHF. These two strains of the organism were grown separately in human histiocyte cells and purification was accomplished over linear Renografin (Squibb, N.J.) density gradient centrifugation.
Propagation of Ehrlichia risticii in Cell Culture:
[0035]E. risticii strains were propagated a human histiocyte (HH) cell line (American Type culture Collection #U937). These cells were grown in RPMI 1640 medium (Flow Laboratories, McLean, Va.), supplemented with 4 mM L-glutamine (M.A. Bioproducts, Walkersville, Md.), and 15% fetal calf serum (Gibco L...
example 2
Isolation of Strain Specific Surface Antigen Gene of Ehrlichia risticii ATCC Type Strain
[0145]Using the procedures outlined in Example 1, the gene encoding the 50 kDa SSA from the ATCC type strain was isolated. The gene sequence and the amino acid sequence encoded thereby is shown in FIG. 4 (SEQ ID NO: 7 and 8).
example 3
Challenge Experiments
Summary
[0146]To study the role of major antigens of E. risticii in protective immune response, we expressed the genes of the 55 kDa, 51 kDa and 85 ′50 kDa-strain-specific antigens of the 90-12 85 kDa antigen and 25-D (50 kDa antigen strains in Escherichia coli. Mice immunized with these purified recombinant proteins of E. risticii developed strong and specific humoral immune response. The recombinant 85 kDa antigen of the 90-12 strain protected mice against challenge infection with both E. risticii strains, whereas its homologue from the 25-D strain, the recombinant 50 kDa antigen, protected mice against only the homologous strain challenge, but not against the heterologous 90-12 strain. Sera from mice immunized with the 85- or 50-kDa antigens did not inhibit the replication of cell-free Ehrlichia in in vitro neutralization assays. Sera from normal mice and mice immunized with other antigens caused non-specific neutralization of E. risticii. Immunoglobulin G fro...
PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
molecular weight | aaaaa | aaaaa |
molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com